References
- Maruyama H, Kawamura H, Takemoto N, Komatsu Y, Aburada M, Hosoya E. Effect of Juzentaihoto on phagocytes. Jpn J Inflamm 1988;8:461–5 (in Japanese).
- Kubota A, Okamura S, Shimoda N, Haranaka R, Omori F, Niho Y. A traditional Chinese herbal medicine, Juzen-taiho-to, augments the production of granulocyte/macrophage colony-stimulating factor from human peripheral blood mononuclear cells in vitro. Int J Immunother 1992;8:191–5.
- Hamada M, Fujii Y, Yamamoto H, Miyazawa Y, Shui SM, Yung YC, et al. Effect of herbal medicine, Zyuzentaihoto, on the immune reactivity of tumor-bearing mice. J Ethnopharma 1988; 24: 311–20
- Kiyohara H, Takemoto N, Komatsu Y, Kawamura H, Hosodya E, Yamada H. Characterization of mitogenic peptic polysaccharides from kampo (Japanese herbal) medicine “juzen-taiho-to”. Planta Med 1991; 57: 254–9
- Ohnishi Y, Fujii H, Hayakawa Y, Sakukawa R, Yamaura T, Sakamoto T, et al. Oral administration of a kampo (Japanese herbal) medicine Juzen-taiho-to inhibits liver metastasis of colon 26-L5 carcinoma cells. Jpn J Cancer Res 1998; 89: 206–13
- Takanashi H, Nakazawa S. Antitumour effect of Juzen-taiho-to, a kampo medicine, for transplanted malignant glioma. Int J Immunother 1995; 11: 65–9
- Sugiyama K, Ueda H, Ichio Y. Protective effect of Juzen-taiho-to against Carboplatin-induced toxic side effects in mice. Biol Pharm Bull 1995; 18: 53–8
- Ohnishi Y, Yasuzumi R, Fan H, Liu L, Takao-Liu F, Komatsu Y, et al. Effects of Juzen-taiho-toh (TJ-48), a traditional oriental medicine, on hematopoietic recovery from radiation injury in mice. Exp Hematol 1990; 18: 18–22
- Abe S, Tansho S, Ishibashi H, Inagaki N, Komatsu Y, Yamaguchi H. Protective effect of oral administration of a traditional medicine, Juzen-Taiho-To, and its components on lethal Candida albicans infection in immunosuppressed mice. Immunopharmacol Immunotoxicol 1998; 20: 421–31
- Kempen MJ, Vaneechoutte M, Claeys G, Verschraegen GL, Vermeiren J, Dhooge I J. Antibiotic susceptibility of acute otitis media pathogens in otitis-prone Belgian children. Eur J Pediatr 2004; 163: 524–9
- Sahm DF, Benninger MS, Evangelista AT, Yee YC, Thornsberry C, Brown N P. Antimicrobial resistance trends among sinus isolates of Streptococcus pneumoniae in the United States. Otolaryngol Head Neck Surg ;136 2001; 2007: 385–9
- Jones ME, Karlowsky JA, Draghi DC, Thornsberry C, Sahm DF, Bradley J S. Rates of antimicrobial resistance among common bacterial pathogens causing respiratory, blood, urine, and skin and soft tissue infections in pediatric patients. Eur J Clin Microbiol Infect Dis 2004; 23: 445–55
- Hayashibara H, Tanimoto K, Nagata I, Harada Y, Shiraki K. Normal levels of IgG subclass in childhood determined by a sensitive ELIZ A. Acta Paediatr Jpn 1993; 35: 113–17
- Hotomi M, Yamanaka N, Saito T, Shimada J, Suzumoto M, Suetake M, et al. Antibody response to the outer membrane protein P6 of non-typeable Haemophilus influenzae and pneumococcal capsular polysaccharides in otitis-prone children. Acta Otolaryngol 1999; 119: 703–7
- Yamanaka N, Faden H. Antibody response to outer membrane protein of non-typeable Haemophilus influenzae in otitis prone children. J Pediatr 1993; 122: 212–18
- Ohya T, Usui Y, Okamoto K, Inoue Y, Arii S, Iwai T. Management for fistula-in-ano with Ginseng and Tang-kuei Ten Combination. Pediatr Int 2004; 46: 72–6
- Ishizaka A, Sakiyama Y, Otsu M, Ozutsumi K, Matsumoto S. Successful intravenous immunoglobulin therapy for recurrent pneumococcal otitis media in young children. Eur J Pediatr 1994; 153: 174–8
- Rosenfeld R M. Surgical prevention of otitis media. Vaccine 2000; 8(Suppl 1)134–9